Senior insider sale
Chief Financial Officer at BICARA THERAPEUTICS INC. — senior position signals high conviction
$1.44M
53K shares
What this filing means
HYEP IVAN plans to sell 53K shares of BICARA THERAPEUTICS INC. valued at approximately $1.44M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/8/2026ACC: 0001969223-26-001009
Officer· Chief Financial Officer
Since Mar 2026
53K
Shares to sell
$1.44M
Approx. market value
12.50K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of stock options
Cash
9/8/2026
12.50KTotal acquired12.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/8/2026 | Exercise of stock options Cash | 12.50K | — |
| Total | 12.50K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
12.50K
Market value
$349.6K
8/10/2026
—Completed
Units to sell
28K
Market value
$807.7K
7/8/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
12.50K
Market value
$283.0K
9/8/2026
Total
Units
53K
Value
$1.44M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/10/2026 | 12.50K | $349.6K | — | Completed |
7/8/2026 | 28K | $807.7K | — | Completed |
| Planned — Approximate Date | ||||
9/8/2026 | 12.50K | $283.0K | NASDAQ | Planned |
| Total | 53K | $1.44M | ||